首页> 外文期刊>Technology analysis & strategic management >Internationalisation of pharmaceutical R&D: how globalised are Europe's largest multinational companies?
【24h】

Internationalisation of pharmaceutical R&D: how globalised are Europe's largest multinational companies?

机译:药品研发的国际化:欧洲最大的跨国公司如何全球化?

获取原文
获取原文并翻译 | 示例
           

摘要

The internationalisation of corporate research is an issue with a large impact on strategic decision-making within the research-intensive pharmaceutical industry. However, sector-wide comparative statistics on the whereabouts of corporate research activities and the geographic distribution of their research partners is scarce. This paper describes the international research profiles of Europe's top 10 largest multinational pharmaceutical companies based on publication counts and author address information drawn from the thousands of pharmaceutical research articles published in 2005-2006. The results provide relevant aggregate-level background intelligence for strategic analysis of the industry's internationalisation processes and research cooperation patterns. The overall statistics indicate that international research activity of European industry is significantly more oriented towards the US science base than vice versa. Company-level statistical data on the research cooperation involving each company's central research centres based in country of corporate headquarters, reveal quite distinctive geographical characteristics alongside differential preferences for in-house or external research partners.
机译:公司研究的国际化是一个问题,对研究密集型制药行业的战略决策产生重大影响。但是,关于公司研究活动的地点及其研究合作伙伴的地理分布的全行业比较统计数据很少。本文根据2005-2006年发表的数千篇药物研究文章中的发表次数和作者地址信息,描述了欧洲十大跨国制药公司的国际研究概况。研究结果为行业的国际化进程和研究合作模式的战略分析提供了相关的综合背景知识。总体统计数据表明,欧洲工业的国际研究活动相对于美国科学基础更为重要,反之亦然。公司级统计数据涉及公司总部所在国家/地区的每个公司的中央研究中心,揭示了非常独特的地理特征以及内部或外部研究合作伙伴的不同偏好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号